A severe shortage hits a drug used for cancer, immune disorders, epilepsy, causing canceled treatments and rationing
Increased demand — along with the time it takes to manufacture the lifesaving immune globulin medicine — has led to limited supplies.
View original article
Contributor: Holly Rosenkrantz
